ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-premature Ejaculation Drug Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18D14064
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anti premature Ejaculation Drug Market Research Report 2023
BUY CHAPTERS

Global Anti-premature Ejaculation Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-18D14064
Report
December 2024
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Menarini Group
Ampio Pharmaceuticals Inc
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
AdvaCare

Anti-premature Ejaculation Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-premature Ejaculation Drug Market

Anti-premature Ejaculation Drug Market

The global Anti-premature Ejaculation Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Anti-premature Ejaculation Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anti-premature Ejaculation Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anti-premature Ejaculation Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-premature Ejaculation Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-premature Ejaculation Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anti-premature Ejaculation Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Anti-premature Ejaculation Drug Market Report

Report Metric Details
Report Name Anti-premature Ejaculation Drug Market
CAGR 5%
Segment by Type
  • Serotonin Reuptake Inhibitors
  • Phosphodiesterase Type 5 Inhibitors
  • Local Anesthetic
  • Others
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Clinic
  • Online Pharmacy
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, AdvaCare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Anti-premature Ejaculation Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Anti-premature Ejaculation Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-premature Ejaculation Drug sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-premature Ejaculation Drug Market report?

Ans: The main players in the Anti-premature Ejaculation Drug Market are Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, AdvaCare

What are the Application segmentation covered in the Anti-premature Ejaculation Drug Market report?

Ans: The Applications covered in the Anti-premature Ejaculation Drug Market report are Hospital, Retail Pharmacy, Clinic, Online Pharmacy

What are the Type segmentation covered in the Anti-premature Ejaculation Drug Market report?

Ans: The Types covered in the Anti-premature Ejaculation Drug Market report are Serotonin Reuptake Inhibitors, Phosphodiesterase Type 5 Inhibitors, Local Anesthetic, Others

1 Study Coverage
1.1 Anti-premature Ejaculation Drug Product Introduction
1.2 Market by Type
1.2.1 Global Anti-premature Ejaculation Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Serotonin Reuptake Inhibitors
1.2.3 Phosphodiesterase Type 5 Inhibitors
1.2.4 Local Anesthetic
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-premature Ejaculation Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Clinic
1.3.5 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-premature Ejaculation Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Anti-premature Ejaculation Drug Revenue by Region
2.2.1 Global Anti-premature Ejaculation Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Anti-premature Ejaculation Drug Revenue by Region (2019-2024)
2.2.3 Global Anti-premature Ejaculation Drug Revenue by Region (2025-2030)
2.2.4 Global Anti-premature Ejaculation Drug Revenue Market Share by Region (2019-2030)
2.3 Global Anti-premature Ejaculation Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Anti-premature Ejaculation Drug Sales by Region
2.4.1 Global Anti-premature Ejaculation Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Anti-premature Ejaculation Drug Sales by Region (2019-2024)
2.4.3 Global Anti-premature Ejaculation Drug Sales by Region (2025-2030)
2.4.4 Global Anti-premature Ejaculation Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-premature Ejaculation Drug Sales by Manufacturers
3.1.1 Global Anti-premature Ejaculation Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Anti-premature Ejaculation Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-premature Ejaculation Drug in 2023
3.2 Global Anti-premature Ejaculation Drug Revenue by Manufacturers
3.2.1 Global Anti-premature Ejaculation Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Anti-premature Ejaculation Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-premature Ejaculation Drug Revenue in 2023
3.3 Global Key Players of Anti-premature Ejaculation Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Anti-premature Ejaculation Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-premature Ejaculation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-premature Ejaculation Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-premature Ejaculation Drug, Product Offered and Application
3.8 Global Key Manufacturers of Anti-premature Ejaculation Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-premature Ejaculation Drug Sales by Type
4.1.1 Global Anti-premature Ejaculation Drug Historical Sales by Type (2019-2024)
4.1.2 Global Anti-premature Ejaculation Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Anti-premature Ejaculation Drug Sales Market Share by Type (2019-2030)
4.2 Global Anti-premature Ejaculation Drug Revenue by Type
4.2.1 Global Anti-premature Ejaculation Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Anti-premature Ejaculation Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Anti-premature Ejaculation Drug Revenue Market Share by Type (2019-2030)
4.3 Global Anti-premature Ejaculation Drug Price by Type
4.3.1 Global Anti-premature Ejaculation Drug Price by Type (2019-2024)
4.3.2 Global Anti-premature Ejaculation Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Anti-premature Ejaculation Drug Sales by Application
5.1.1 Global Anti-premature Ejaculation Drug Historical Sales by Application (2019-2024)
5.1.2 Global Anti-premature Ejaculation Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Anti-premature Ejaculation Drug Sales Market Share by Application (2019-2030)
5.2 Global Anti-premature Ejaculation Drug Revenue by Application
5.2.1 Global Anti-premature Ejaculation Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Anti-premature Ejaculation Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Anti-premature Ejaculation Drug Revenue Market Share by Application (2019-2030)
5.3 Global Anti-premature Ejaculation Drug Price by Application
5.3.1 Global Anti-premature Ejaculation Drug Price by Application (2019-2024)
5.3.2 Global Anti-premature Ejaculation Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Anti-premature Ejaculation Drug Market Size by Type
6.1.1 US & Canada Anti-premature Ejaculation Drug Sales by Type (2019-2030)
6.1.2 US & Canada Anti-premature Ejaculation Drug Revenue by Type (2019-2030)
6.2 US & Canada Anti-premature Ejaculation Drug Market Size by Application
6.2.1 US & Canada Anti-premature Ejaculation Drug Sales by Application (2019-2030)
6.2.2 US & Canada Anti-premature Ejaculation Drug Revenue by Application (2019-2030)
6.3 US & Canada Anti-premature Ejaculation Drug Market Size by Country
6.3.1 US & Canada Anti-premature Ejaculation Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Anti-premature Ejaculation Drug Sales by Country (2019-2030)
6.3.3 US & Canada Anti-premature Ejaculation Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-premature Ejaculation Drug Market Size by Type
7.1.1 Europe Anti-premature Ejaculation Drug Sales by Type (2019-2030)
7.1.2 Europe Anti-premature Ejaculation Drug Revenue by Type (2019-2030)
7.2 Europe Anti-premature Ejaculation Drug Market Size by Application
7.2.1 Europe Anti-premature Ejaculation Drug Sales by Application (2019-2030)
7.2.2 Europe Anti-premature Ejaculation Drug Revenue by Application (2019-2030)
7.3 Europe Anti-premature Ejaculation Drug Market Size by Country
7.3.1 Europe Anti-premature Ejaculation Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Anti-premature Ejaculation Drug Sales by Country (2019-2030)
7.3.3 Europe Anti-premature Ejaculation Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-premature Ejaculation Drug Market Size
8.1.1 China Anti-premature Ejaculation Drug Sales (2019-2030)
8.1.2 China Anti-premature Ejaculation Drug Revenue (2019-2030)
8.2 China Anti-premature Ejaculation Drug Market Size by Application
8.2.1 China Anti-premature Ejaculation Drug Sales by Application (2019-2030)
8.2.2 China Anti-premature Ejaculation Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Anti-premature Ejaculation Drug Market Size by Type
9.1.1 Asia Anti-premature Ejaculation Drug Sales by Type (2019-2030)
9.1.2 Asia Anti-premature Ejaculation Drug Revenue by Type (2019-2030)
9.2 Asia Anti-premature Ejaculation Drug Market Size by Application
9.2.1 Asia Anti-premature Ejaculation Drug Sales by Application (2019-2030)
9.2.2 Asia Anti-premature Ejaculation Drug Revenue by Application (2019-2030)
9.3 Asia Anti-premature Ejaculation Drug Sales by Region
9.3.1 Asia Anti-premature Ejaculation Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Anti-premature Ejaculation Drug Revenue by Region (2019-2030)
9.3.3 Asia Anti-premature Ejaculation Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Menarini Group
11.1.1 Menarini Group Company Information
11.1.2 Menarini Group Overview
11.1.3 Menarini Group Anti-premature Ejaculation Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Menarini Group Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Menarini Group Recent Developments
11.2 Ampio Pharmaceuticals Inc
11.2.1 Ampio Pharmaceuticals Inc Company Information
11.2.2 Ampio Pharmaceuticals Inc Overview
11.2.3 Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ampio Pharmaceuticals Inc Recent Developments
11.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
11.3.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
11.3.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Overview
11.3.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments
11.4 AdvaCare
11.4.1 AdvaCare Company Information
11.4.2 AdvaCare Overview
11.4.3 AdvaCare Anti-premature Ejaculation Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 AdvaCare Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AdvaCare Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-premature Ejaculation Drug Industry Chain Analysis
12.2 Anti-premature Ejaculation Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-premature Ejaculation Drug Production Mode & Process
12.4 Anti-premature Ejaculation Drug Sales and Marketing
12.4.1 Anti-premature Ejaculation Drug Sales Channels
12.4.2 Anti-premature Ejaculation Drug Distributors
12.5 Anti-premature Ejaculation Drug Customers
13 Market Dynamics
13.1 Anti-premature Ejaculation Drug Industry Trends
13.2 Anti-premature Ejaculation Drug Market Drivers
13.3 Anti-premature Ejaculation Drug Market Challenges
13.4 Anti-premature Ejaculation Drug Market Restraints
14 Key Findings in The Global Anti-premature Ejaculation Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Menarini Group
Ampio Pharmaceuticals Inc
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
AdvaCare
List of Tables
    Table 1. Global Anti-premature Ejaculation Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Serotonin Reuptake Inhibitors
    Table 3. Major Manufacturers of Phosphodiesterase Type 5 Inhibitors
    Table 4. Major Manufacturers of Local Anesthetic
    Table 5. Major Manufacturers of Others
    Table 6. Global Anti-premature Ejaculation Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Anti-premature Ejaculation Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Anti-premature Ejaculation Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Anti-premature Ejaculation Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Anti-premature Ejaculation Drug Revenue Market Share by Region (2019-2024)
    Table 11. Global Anti-premature Ejaculation Drug Revenue Market Share by Region (2025-2030)
    Table 12. Global Anti-premature Ejaculation Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Anti-premature Ejaculation Drug Sales by Region (2019-2024) & (K Units)
    Table 14. Global Anti-premature Ejaculation Drug Sales by Region (2025-2030) & (K Units)
    Table 15. Global Anti-premature Ejaculation Drug Sales Market Share by Region (2019-2024)
    Table 16. Global Anti-premature Ejaculation Drug Sales Market Share by Region (2025-2030)
    Table 17. Global Anti-premature Ejaculation Drug Sales by Manufacturers (2019-2024) & (K Units)
    Table 18. Global Anti-premature Ejaculation Drug Sales Share by Manufacturers (2019-2024)
    Table 19. Global Anti-premature Ejaculation Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Anti-premature Ejaculation Drug Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Anti-premature Ejaculation Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Anti-premature Ejaculation Drug Price by Manufacturers 2019-2024 (US$/Unit)
    Table 23. Global Anti-premature Ejaculation Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Anti-premature Ejaculation Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-premature Ejaculation Drug as of 2023)
    Table 25. Global Key Manufacturers of Anti-premature Ejaculation Drug, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Anti-premature Ejaculation Drug, Product Offered and Application
    Table 27. Global Key Manufacturers of Anti-premature Ejaculation Drug, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Anti-premature Ejaculation Drug Sales by Type (2019-2024) & (K Units)
    Table 30. Global Anti-premature Ejaculation Drug Sales by Type (2025-2030) & (K Units)
    Table 31. Global Anti-premature Ejaculation Drug Sales Share by Type (2019-2024)
    Table 32. Global Anti-premature Ejaculation Drug Sales Share by Type (2025-2030)
    Table 33. Global Anti-premature Ejaculation Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Anti-premature Ejaculation Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Anti-premature Ejaculation Drug Revenue Share by Type (2019-2024)
    Table 36. Global Anti-premature Ejaculation Drug Revenue Share by Type (2025-2030)
    Table 37. Anti-premature Ejaculation Drug Price by Type (2019-2024) & (US$/Unit)
    Table 38. Global Anti-premature Ejaculation Drug Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 39. Global Anti-premature Ejaculation Drug Sales by Application (2019-2024) & (K Units)
    Table 40. Global Anti-premature Ejaculation Drug Sales by Application (2025-2030) & (K Units)
    Table 41. Global Anti-premature Ejaculation Drug Sales Share by Application (2019-2024)
    Table 42. Global Anti-premature Ejaculation Drug Sales Share by Application (2025-2030)
    Table 43. Global Anti-premature Ejaculation Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Anti-premature Ejaculation Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Anti-premature Ejaculation Drug Revenue Share by Application (2019-2024)
    Table 46. Global Anti-premature Ejaculation Drug Revenue Share by Application (2025-2030)
    Table 47. Anti-premature Ejaculation Drug Price by Application (2019-2024) & (US$/Unit)
    Table 48. Global Anti-premature Ejaculation Drug Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 49. US & Canada Anti-premature Ejaculation Drug Sales by Type (2019-2024) & (K Units)
    Table 50. US & Canada Anti-premature Ejaculation Drug Sales by Type (2025-2030) & (K Units)
    Table 51. US & Canada Anti-premature Ejaculation Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Anti-premature Ejaculation Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Anti-premature Ejaculation Drug Sales by Application (2019-2024) & (K Units)
    Table 54. US & Canada Anti-premature Ejaculation Drug Sales by Application (2025-2030) & (K Units)
    Table 55. US & Canada Anti-premature Ejaculation Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Anti-premature Ejaculation Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Anti-premature Ejaculation Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Anti-premature Ejaculation Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Anti-premature Ejaculation Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Anti-premature Ejaculation Drug Sales by Country (2019-2024) & (K Units)
    Table 61. US & Canada Anti-premature Ejaculation Drug Sales by Country (2025-2030) & (K Units)
    Table 62. Europe Anti-premature Ejaculation Drug Sales by Type (2019-2024) & (K Units)
    Table 63. Europe Anti-premature Ejaculation Drug Sales by Type (2025-2030) & (K Units)
    Table 64. Europe Anti-premature Ejaculation Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Anti-premature Ejaculation Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Anti-premature Ejaculation Drug Sales by Application (2019-2024) & (K Units)
    Table 67. Europe Anti-premature Ejaculation Drug Sales by Application (2025-2030) & (K Units)
    Table 68. Europe Anti-premature Ejaculation Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Anti-premature Ejaculation Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Anti-premature Ejaculation Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Anti-premature Ejaculation Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Anti-premature Ejaculation Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Anti-premature Ejaculation Drug Sales by Country (2019-2024) & (K Units)
    Table 74. Europe Anti-premature Ejaculation Drug Sales by Country (2025-2030) & (K Units)
    Table 75. China Anti-premature Ejaculation Drug Sales by Type (2019-2024) & (K Units)
    Table 76. China Anti-premature Ejaculation Drug Sales by Type (2025-2030) & (K Units)
    Table 77. China Anti-premature Ejaculation Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Anti-premature Ejaculation Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Anti-premature Ejaculation Drug Sales by Application (2019-2024) & (K Units)
    Table 80. China Anti-premature Ejaculation Drug Sales by Application (2025-2030) & (K Units)
    Table 81. China Anti-premature Ejaculation Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Anti-premature Ejaculation Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Anti-premature Ejaculation Drug Sales by Type (2019-2024) & (K Units)
    Table 84. Asia Anti-premature Ejaculation Drug Sales by Type (2025-2030) & (K Units)
    Table 85. Asia Anti-premature Ejaculation Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Anti-premature Ejaculation Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Anti-premature Ejaculation Drug Sales by Application (2019-2024) & (K Units)
    Table 88. Asia Anti-premature Ejaculation Drug Sales by Application (2025-2030) & (K Units)
    Table 89. Asia Anti-premature Ejaculation Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Anti-premature Ejaculation Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Anti-premature Ejaculation Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Anti-premature Ejaculation Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Anti-premature Ejaculation Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Anti-premature Ejaculation Drug Sales by Region (2019-2024) & (K Units)
    Table 95. Asia Anti-premature Ejaculation Drug Sales by Region (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Type (2019-2024) & (K Units)
    Table 97. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Type (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Application (2019-2024) & (K Units)
    Table 101. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Application (2025-2030) & (K Units)
    Table 102. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Country (2019-2024) & (K Units)
    Table 108. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales by Country (2025-2030) & (K Units)
    Table 109. Menarini Group Company Information
    Table 110. Menarini Group Description and Major Businesses
    Table 111. Menarini Group Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 112. Menarini Group Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Menarini Group Recent Developments
    Table 114. Ampio Pharmaceuticals Inc Company Information
    Table 115. Ampio Pharmaceuticals Inc Description and Major Businesses
    Table 116. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 117. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Ampio Pharmaceuticals Inc Recent Developments
    Table 119. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
    Table 120. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Description and Major Businesses
    Table 121. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 122. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments
    Table 124. AdvaCare Company Information
    Table 125. AdvaCare Description and Major Businesses
    Table 126. AdvaCare Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 127. AdvaCare Anti-premature Ejaculation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. AdvaCare Recent Developments
    Table 129. Key Raw Materials Lists
    Table 130. Raw Materials Key Suppliers Lists
    Table 131. Anti-premature Ejaculation Drug Distributors List
    Table 132. Anti-premature Ejaculation Drug Customers List
    Table 133. Anti-premature Ejaculation Drug Market Trends
    Table 134. Anti-premature Ejaculation Drug Market Drivers
    Table 135. Anti-premature Ejaculation Drug Market Challenges
    Table 136. Anti-premature Ejaculation Drug Market Restraints
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-premature Ejaculation Drug Product Picture
    Figure 2. Global Anti-premature Ejaculation Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anti-premature Ejaculation Drug Market Share by Type in 2023 & 2030
    Figure 4. Serotonin Reuptake Inhibitors Product Picture
    Figure 5. Phosphodiesterase Type 5 Inhibitors Product Picture
    Figure 6. Local Anesthetic Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Anti-premature Ejaculation Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Anti-premature Ejaculation Drug Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Retail Pharmacy
    Figure 12. Clinic
    Figure 13. Online Pharmacy
    Figure 14. Anti-premature Ejaculation Drug Report Years Considered
    Figure 15. Global Anti-premature Ejaculation Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Anti-premature Ejaculation Drug Revenue 2019-2030 (US$ Million)
    Figure 17. Global Anti-premature Ejaculation Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Anti-premature Ejaculation Drug Revenue Market Share by Region (2019-2030)
    Figure 19. Global Anti-premature Ejaculation Drug Sales 2019-2030 ((K Units)
    Figure 20. Global Anti-premature Ejaculation Drug Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada Anti-premature Ejaculation Drug Sales YoY (2019-2030) & (K Units)
    Figure 22. US & Canada Anti-premature Ejaculation Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Anti-premature Ejaculation Drug Sales YoY (2019-2030) & (K Units)
    Figure 24. Europe Anti-premature Ejaculation Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China Anti-premature Ejaculation Drug Sales YoY (2019-2030) & (K Units)
    Figure 26. China Anti-premature Ejaculation Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) Anti-premature Ejaculation Drug Sales YoY (2019-2030) & (K Units)
    Figure 28. Asia (excluding China) Anti-premature Ejaculation Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales YoY (2019-2030) & (K Units)
    Figure 30. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The Anti-premature Ejaculation Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of Anti-premature Ejaculation Drug in the World: Market Share by Anti-premature Ejaculation Drug Revenue in 2023
    Figure 33. Global Anti-premature Ejaculation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global Anti-premature Ejaculation Drug Sales Market Share by Type (2019-2030)
    Figure 35. Global Anti-premature Ejaculation Drug Revenue Market Share by Type (2019-2030)
    Figure 36. Global Anti-premature Ejaculation Drug Sales Market Share by Application (2019-2030)
    Figure 37. Global Anti-premature Ejaculation Drug Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Anti-premature Ejaculation Drug Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada Anti-premature Ejaculation Drug Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada Anti-premature Ejaculation Drug Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada Anti-premature Ejaculation Drug Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada Anti-premature Ejaculation Drug Revenue Share by Country (2019-2030)
    Figure 43. US & Canada Anti-premature Ejaculation Drug Sales Share by Country (2019-2030)
    Figure 44. U.S. Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Anti-premature Ejaculation Drug Sales Market Share by Type (2019-2030)
    Figure 47. Europe Anti-premature Ejaculation Drug Revenue Market Share by Type (2019-2030)
    Figure 48. Europe Anti-premature Ejaculation Drug Sales Market Share by Application (2019-2030)
    Figure 49. Europe Anti-premature Ejaculation Drug Revenue Market Share by Application (2019-2030)
    Figure 50. Europe Anti-premature Ejaculation Drug Revenue Share by Country (2019-2030)
    Figure 51. Europe Anti-premature Ejaculation Drug Sales Share by Country (2019-2030)
    Figure 52. Germany Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 53. France Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 57. China Anti-premature Ejaculation Drug Sales Market Share by Type (2019-2030)
    Figure 58. China Anti-premature Ejaculation Drug Revenue Market Share by Type (2019-2030)
    Figure 59. China Anti-premature Ejaculation Drug Sales Market Share by Application (2019-2030)
    Figure 60. China Anti-premature Ejaculation Drug Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Anti-premature Ejaculation Drug Sales Market Share by Type (2019-2030)
    Figure 62. Asia Anti-premature Ejaculation Drug Revenue Market Share by Type (2019-2030)
    Figure 63. Asia Anti-premature Ejaculation Drug Sales Market Share by Application (2019-2030)
    Figure 64. Asia Anti-premature Ejaculation Drug Revenue Market Share by Application (2019-2030)
    Figure 65. Asia Anti-premature Ejaculation Drug Revenue Share by Region (2019-2030)
    Figure 66. Asia Anti-premature Ejaculation Drug Sales Share by Region (2019-2030)
    Figure 67. Japan Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 71. India Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America Anti-premature Ejaculation Drug Sales Share by Country (2019-2030)
    Figure 78. Brazil Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries Anti-premature Ejaculation Drug Revenue (2019-2030) & (US$ Million)
    Figure 83. Anti-premature Ejaculation Drug Value Chain
    Figure 84. Anti-premature Ejaculation Drug Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Anaesthesia Epidural Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35M13316
Thu Mar 06 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ketamine Hydrochloride API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9E15190
Thu Mar 06 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Medical Metered Dose Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24F14648
Thu Mar 06 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global OTC Scar Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13J12359
Thu Mar 06 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions